Around the Helix: Cell and Gene Therapy Company Updates – July 2, 2025
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
ImmunoLogic, Episode 4: "Inflammatory Storms and Gentle Balances: Navigating Toxicities in Immunotherapies" With Caroline Diorio, MD, FRCPC, FAAP
In Episode 4 of ImmunoLogic, Caroline Diorio, MD, FRCPC, FAAP, discussed her research on adverse events associated with cell therapy.
FDA Activity Recap: June 2025 Features New Platform Designation, IND Clearance, and More
Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.
ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD
In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.
CGTLive®’s Weekly Rewind – June 27, 2025
Review top news and interview highlights from the week ending June 27, 2025.
enGene Snags FDA RMAT Designation for Bladder Cancer Gene Therapy Detalimogene
The gene therapy is currently being evaluated in the phase 1/2 LEGEND clinical trial.
